In 2023, the size of the <b>Acute Heart Failure (AHF) Therapeutics Industry</b> was valued at <b>USD 9.5 billion</b> and is anticipated to reach <b>USD 14.8 billion</b> by 2033, expanding at a <b>4.5%</b> CAGR between 2024 and 2033. The report encompasses multiple segments and provides an analysis of significant trends and factors impacting the market.
